Quantcast

Latest Boston Scientific Stories

2014-08-29 16:23:57

MENLO PARK, Calif., Aug. 29, 2014 /PRNewswire/ -- Medina Medical announced today that Mr. Engelson joined Medina Medical as CEO and member of the Board of Directors on August 18, 2014. Mr. Engelson brings three decades of medical device development and commercialization experience, including over a decade of direct experience in Medina Medical's field. Mr. Engelson previously served as a Partner of the medical device incubator The Foundry, after having served as President and CEO of...

2014-08-25 16:27:13

MALBOROUGH, Mass., Aug. 25, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2014 Morgan Stanley Global Healthcare Conference on September 8 in New York, NY. Mike Mahoney, chief executive officer, and Dan Brennan, executive vice president and chief financial officer, will participate in a 35-minute question and answer session regarding the company beginning at approximately 9:55 a.m. ET. A live webcast of the question and answer...

2014-08-19 04:22:48

Companies Reach Agreement to Develop a New and Differentiated FFR Guidewire and Next Generation Boston Scientific Rotablator(TM) RotaWire(TM) MARLBOROUGH, Mass. and NAGOYA, Japan, Aug. 19, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and ASAHI INTECC (Securities Code 7747, Second Section, Tokyo and Nagoya Stock Exchange) have formalized plans to develop a new, differentiated fractional flow reserve (FFR) wire. The joint project focuses on creating a device intended...

2014-08-05 23:01:02

Neuromodulation is the fastest growing segment within the U.S. Neurological Market and is projected to experience double-digit growth, reports iData Research Vancouver, BC (PRWEB) August 05, 2014 According to a new report series by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the U.S. Neuromodulation Device Market is projected to grow at a CAGR of over 10% from 2013 to 2020. This market represents the largest and fastest...

2014-07-22 08:32:41

Easy to Use Imaging System to Support Planned Intravascular Ultrasound and Fractional Flow Reserve Products MARLBOROUGH, Mass., July 22, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated full commercial launch of the new POLARIS(TM) Imaging System. This system will support the Boston Scientific family of intravascular ultrasound (IVUS) catheters, including coronary, peripheral and intra-cardiac echo products. The POLARIS System offers enhanced ease-of-use...

2014-07-14 08:27:37

Innovative Technology Strengthens Company's Leading Portfolio of Solutions for Peripheral Vascular Disease MARLBOROUGH, Mass., July 14, 2014 /PRNewswire/ -- Demonstrating its continued leadership in the development of innovative solutions for peripheral vascular disease, Boston Scientific Corporation (NYSE: BSX) has received CE Mark for the Ranger(TM) Paclitaxel-Coated PTA Balloon Catheter. The technology is now in full European market launch. The Ranger Drug-Coated Balloon (DCB)...

2014-07-01 08:29:58

MARLBOROUGH, Mass., July 1, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results, business highlights and outlook for the second quarter ended June 30, 2014 on Thursday, July 24, 2014 at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, president and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. A live webcast of the conference call will be available via...

2014-06-03 12:36:31

NATICK, Mass., June 3, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Wells Fargo 2014 Healthcare Conference on June 17 in Boston, MA. Dan Brennan, executive vice president and chief financial officer, and Susan Lisa, vice president, Investor Relations, will participate in a 30-minute question and answer session regarding the company beginning at approximately 8:50 a.m. ET. A live webcast of the question and answer session will be...

2014-06-03 08:32:11

NATICK, Mass., June 3, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Goldman Sachs 35th Annual Global Healthcare Conference on June 10 in Rancho Palos Verdes, CA. David Pierce, senior vice president and president, Endoscopy, and Susan Lisa, vice president, Investor Relations, will participate in a 35-minute question and answer session regarding the company beginning at approximately 9:20 a.m. PT. A live webcast of the question and...

2014-05-12 23:00:11

Humility of Mary Health Partners is among the first healthcare providers in the country to implant the world’s first commercially available subcutaneous implantable defibrillator. Youngstown, Ohio (PRWEB) May 13, 2014 Humility of Mary Health Partners is among the first healthcare providers in the country to implant a revolutionary new cardiac defibrillator under the skin of patients at risk for sudden cardiac arrest. The new device, called an S-ICD, was developed by Cameron...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related